To test the clinical significance of these relationships, we used partial correlation analyses to demonstrate that BAZ1A and SMARCA5 expression, as well as other VDR-interacting proteins identified in cell lines by RIME, were able to significantly strengthen the correlations between VDR and AA cistrome genes in AA prostate cancer. This evidence concerns the gene SMARCA5 and prostate cancer.